Mesa Labs (MLAB) Director Ladiwala Receives 3,810 RSU Shares

What Happened

• Ladiwala Shiraz Shabanali, a director of Mesa Laboratories, had 3,810 restricted stock units (RSUs) vest on August 15, 2026. The Form 4 records the conversion/exercise of 3,810 derivative units into common shares (acquisition) and a simultaneous disposition of 3,810 shares, both reported at $0.00. The filing shows no cash paid or sale proceeds reported.

Key Details

• Transaction date: 2026-08-15 (filed 2026-08-17; filing appears timely)
• Reported transactions: Exercise/conversion of derivative (code M) — 3,810 shares acquired @ $0.00 and 3,810 shares disposed @ $0.00
• Footnotes: F1 — each RSU equals one share; F2 — RSUs vested on Aug 15, 2026; F3 — Not applicable
• Shares owned after transaction: Not specified in the provided filing excerpt
• No 10b5-1 plan, tax-withholding, or sale-for-cash details are stated in the filing

Context

• The filing records a derivative conversion of vested RSUs rather than an open‑market purchase or voluntary sale. Reporting both an acquisition and a simultaneous disposition at $0.00 is consistent with RSU settlement mechanics (conversion of awards and related processing), but the Form 4 here does not specify why the disposition occurred or whether any shares were withheld for taxes. This transaction reflects award settlement, not a market‑purchase signal.